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ImmunoprecipitationTropomyosin‐receptor‐kinase B (TrkB receptor) activation plays an important role in the survival of retinal gan-
glion cells (RGCs). This study reports a novel ﬁnding that, SH2 domain-containing phosphatase-2 (Shp-2) binds
to the TrkB receptor in RGCs and negatively regulates its activity under glaucomatous stress. This enhanced bind-
ing of TrkB and Shp2 is mediated through caveolin. Caveolin 1 and 3 undergo hyper-phosphorylation in RGCs
under stress and bind to the Shp2 phosphatase. Shp2 undergoes activation under glaucomatous stress conditions
in RGCs in vivowith a concurrent loss of TrkB activity. Inhibiting the Shp2 phosphatase restored TrkB activity in
cells exposed to excitotoxic and oxidative stress. Collectively, these ﬁndings implicate a molecular basis of Shp2
mediated TrkB deactivation leading to RGC degeneration observed in glaucoma.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Glaucoma is a chronic disease involving irreversible loss of retinal
ganglion cells (RGCs). Mechanisms for cell damage are not well under-
stood, with elevated intraocular pressure (IOP) being themajor risk fac-
tor. Tropomyosin-receptor-kinase B (TrkB), a member of the Trk family
of receptor tyrosine kinases, is well expressed in RGCs [1–3] and plays a
major role in their preferential degeneration in glaucoma [4]. BDNF and
NT4 are the high afﬁnity ligands for the TrkB receptor and their binding
stimulates dimerization and autophosphorylation of the TrkB receptor
and stimulates themajor downstreampro-survival signalling pathways
involving PI3K, phospholipase C-γ1 and MAPK [5]. TrkB activation
through exogenously administered BDNF can rescue RGCs transiently
but higher doses or multiple applications fail to support their long term
survival as RGCs eventually get desensitised to the protective effects of
BDNF [4,6]. TrkB gene therapy and BDNF treatment have a protective
effect on dying RGCs [7]. The precise mechanism underlying a change
in sensitivity of TrkB to BDNF treatment is poorly understood. Receptor
tyrosine kinases are subjected to phosphorylation and dephosphorylation
events in tandem, for biological actions and tomaintain a ﬁne equilibriumin derived neurotrophic factor;
erve; IOP, intra-ocular pressure
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rights reserved.in the downstream signalling events [8]. Therefore, simultaneous dephos-
phorylation and deactivation of TrkB by an interacting phosphatase may
restrain the protective effects of BDNF.
Shp-2 is a ubiquitously expressed tyrosine phosphatase that acts as a
regulator of tyrosine kinase receptor signalling [9]. It has also been impli-
cated in the signalling of TrkA receptors [10]. Shp2 regulates the down-
stream signalling of TrkB in mesencephalic and cortical neurons [11]. In
cerebral neuronal cultures, Shp2negatively regulates TrkB autophospho-
rylation and activation through BDNF in a calcium dependent manner
[12].
In this study, we revealmolecular evidence that the Shp2–TrkB inter-
action in RGCs is mediated through the adapter protein caveolin (cav).
Shp2 also interacts with the adapter proteins Gab and FRS2/SNT [12].
Cav, a principal component of Caveolae, comprises cav1, 2 and 3 isoforms
and is well expressed in the retina [13,14]. In this report, we uncovered a
novel mechanism of TrkB receptor deactivation by Shp2 phosphatase,
under glaucomatous stress conditions in RGCs in vivo.
2. Materials and methods
2.1. Animals
All procedures involving animals were conducted in accordance with
theAustralian code of practice for the care and use of animals for scientiﬁc
purposes and the guidelines of the ARVO statement for the use of animals
in ophthalmic and vision research. Albino Sprague–Dawley rats were
obtained from Animal Research Centre, Perth and maintained in our vi-
varium in cyclic light (12 h on; 12 h off; ~300 lux). All animals were
1644 V.K. Gupta et al. / Biochimica et Biophysica Acta 1822 (2012) 1643–1649maintained in an air-conditioned room with controlled temperature
(21±2 °C). The animals were anaesthetised with an intraperitoneal in-
jection of ketamine (75 mg/kg) and medetomidine (0.5 mg/kg).
2.2. Optic nerve axotomy and intra-ocular injections
An optic nerve transection was performed at a distance of 2–3 mm
from the globe using a surgical protocol described previously [15] and
veriﬁed by the loss of visual evoked potentials [16–18]. A chronic RGC
degeneration model was established by a chronic increase of intra-
ocular pressure (IOP) in rats by microbead (Fluospheres, Molecular
Probes, 10 μm) injections in the anterior chamber as reported previ-
ously [19,20]. Intraocular injections (3.6×106 microbeads/mL, 5 μL)
were made every week until a sustained increase in IOP was observed
and the contralateral eye injectedwith an equivalent volume of saline. All
the eyes injected with microbeads experienced a sustained increase of
20.4±1.4 mm Hg for 6 weeks from a baseline IOP of 11.1±0.4 mm Hg
(Icare-LAB tonometer), while the control eyes depicted no such elevation
of IOP. The animals which did not depict a sustained IOP increase of at
least 18 mm Hg or above were strictly discarded. Four consecutive IOP
readings were obtained from each eye and the average number was
taken as the IOP for that time point.
For the anti-sense oligonucleotides (AON) a 33-gauge needle was
used for injections (5 μL) at a 45° angle 2 mm behind the corneoscleral
limbus into the vitreous body without touching the lens. After the in-
jection, the needle was left in place for another minute to allow dis-
persion of the oligonucleotides into the vitreous. The experimental
eyeswere injectedwith AON, and the contralateral eyeswith scrambled
oligonucleotides.
2.3. Knock down of caveolin expression
Caveolin expression was knocked down in the RGCs in vivo using
intravitreal injections of phosphorthioate modiﬁed cav mRNA AONs
[21]. AONs can penetrate through the cell membrane and arrest the
translation of speciﬁc mRNA, leading to the inhibition of biosynthesis
of the corresponding protein [21]. The treatment of AONs with
polyethyleneimine (PEI) compactly packs them into ﬁne nano particles
which further helps them cross themembrane barrier in themammalian
cells [22–25]. Ratswere intravitreally injected eitherwith cav AON (every
week) or a scrambled control treatedwith PEI resulting in knock down of
cav in retina compared to controls (Fig. 6). AONs were generated corre-
sponding to the homologous region of cav1, 2 and 3 to knock down ex-
pression of all cav isoforms. The AONs were also used to knock down
the expression of cav isoforms in primary RGC culture. Cav AON:
5′-mC*mC*mG*mC*mA*mA*T*C*A*C*A*T*C*T*T*C*A*A*A*G*mU*mC*
mA*mA*mU*mC-3′. Scrambled: 5′-mC*mC*mC*mA*mU*mA*A*C*A*T*
T*C*G*A*A*C*A*A*G*T*mC*mC*mA*mU*mU*mC-3′. (*-Phosphorthioate;
m-2′ O-methyl RNA base — IDT Technologies, Australia). The se-
quence of AONs corresponded to cav1 α-195–220 (AF439778.1), cav1
β-102–127 (AF439779.1), cav-2 150–175 (AF439780.1), cav-3 114–139
(U31968.1) mRNA sequence (EMBL-EBI).
2.4. Isolation of retinal ganglion cells and culture
Following rat retinal dissociation, the cellular suspension was treat-
ed with CD90.1 MicroBeads which led to selective magnetic labelling of
the RGCs. The labelled RGCs were pre-enriched as per manufacturer's
instructions (Miltenyi Biotec GmbH) and passed through columns
subjected to strong magnetic ﬁeld and eluted [26,27]. Brn3a (Abcam),
Thy-1 (Cell Signalling) and GFAP (Sigma) antibodies were used to fol-
low the enrichment of RGCs from thewhole retinal cells and quantiﬁed.
RGCs were either used directly or maintained in culture (Neurobasal-A
media with 2% B-27, GIBCO) in 20 μg/mL poly-D-lysine (Sigma) coated
plates and transfected using Lipofectamine RNAiMAX (Invitrogen).
The cells were collected for experiments approximately 24 h aftertransfection. RGC-5 cells weremaintained in DMEMmedium containing
10% (vol/vol) foetal bovine serum at 37 °C in 5% CO2. Approximately
2.0×105 cells were seeded in each culture dish 6–12 h before treatment.
Subsequently, cells were treated either with Glu (25 μM)+H2O2 (2 μM)
or Shp2 inhibitor (PHPS1; 5 μM) or both of these for 24 h followed by
lysing the cells and subjecting them to western blotting.
2.5. Western blotting and immunoprecipitations
RGCs were lysed in lysis buffer (20 mM HEPES, pH 7.4, 1% Triton
X-100, 1 mM EDTA) containing (10 μg/ml aprotinin, 10 μM leupeptin,
1 mMPMSF) and (1 mMNaVO3, 100 mMNaF, 1 mMNa2MoO4, 10 mM
Na4P2O7). The proteins were resolved by 10% SDS-PAGE and transferred
to PVDFmembrane as explained previously [28] and the blots developed
using ECL kit (Pierce). Immunoprecipitationwas carried out according to
the method described earlier [29] and immunoprecipitates subjected to
assay procedures or immunoblot analysis with indicated antibodies in
the respective ﬁgures. Band intensities were normalised to the total
amount of protein immunoprecipitated in each case and quantiﬁed in
the linear range of detection using ImageJ software (NIH, USA).
2.6. Shp-2 phosphatase assay
Shp2 enzyme assays were performed following immunoprecipita-
tion, using pNPP (1 mg/mL) as substrate in buffer containing 50 mM
imidazole (pH 7.5) and 5 mMdithiothreitol as described previously [30]
and absorbancewasmeasured at 410 nmusing Flex Station 3microplate
reader.
2.7. TrkB tyrosine kinase assay
The TrkBkinase assayswere performed following immunoprecipita-
tions using anti-TrkB antibody (Santa Cruz, CA, 0.5 μg) bymodiﬁcations
of the methods reported previously [31,32]. The kinase reaction was
performed at room temperature in kinase assay buffer (50 mM HEPES,
pH 7.4, 12 mM MgCl2, and 5 mM MnCl2) containing 100 μM ATP and
3 mg/mL poly-Glu:Tyr peptide (Cell Signalling) for 30 min. The soluble
peptide (100 μL) was then coated on the microplates overnight as
reported previously [33] and the plate was washed three times with
PBS containing 0.05% Tween-20 followed by adding 100 μL of pY100
(Cell Signalling, 1:500) antibody and then HRP-linked secondary anti-
body. The plate was re-incubated at 37 °C for 1 h and washed. Finally,
100 μL of tetramethylbenzidine (Sigma) was added and incubated at
room temperature for 30 min and A650 measured using Flex Station 3
microplate reader.
2.8. Statistical analysis
Data were analysed and graphed using GraphPad Prism software
(GraphPad Software, CA). All values are mean±SD from given n sizes
and compared by Student's t test for unpaired data. The signiﬁcance
was set at pb0.05.
3. Results
3.1. Enhanced interaction of TrkB with Shp2 in RGCs under stress conditions
An acute and a chronic RGC degeneration models were established
with either complete optic nerve (ON) axotomy or repeat microbead
administration into the anterior chamber leading to chronic increase of
IOP respectively. The RGCs were isolated from the rat retinas subjected
to optic nerve axotomy (1 week) and those exposed to chronically in-
creased IOP (4 weeks) [26,27]. The increase of RGC markers Thy-1 and
Brn3a and loss of major contaminant Müller glial cell marker GFAP indi-
cated an enrichment of the RGCs (Fig. 1A). Thy-1 expression in thewhole
rat retina was 0.75±0.3% (pb0.003) of the expression observed in the
Fig. 1. TrkB interacts with Shp2 in RGCs and this interaction is enhanced under stress conditions. A. Enrichment of the RGC fraction indicated by Thy-1 and Brn3a and loss of stan-
dard contaminating Muller glial cell marker, GFAP. B. Densitometric analysis of the band intensities in (A) to quantify the enrichment of RGCs. C. Immunoprecipitations of TrkB and
Shp2 establish that the two proteins reciprocally interact in rat RGCs in vivo. Whole cell lysates and non-immune IgG were used as controls. D, E. An augmented TrkB and Shp2
co-immunoprecipitation is observed in RGCs isolated from retinas exposed to stress following ON axotomy and exposure to chronically increased IOP. Densitometric analysis of
TrkB binding to Shp2 and vice versa. Data are mean±SD, n=3 each, *pb0.001.
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compared to that of the isolated RGCs while in contrast, GFAP expression
in the isolated RGC fractionwas depleted to 10.2±4.5% (pb0.007) of that
detected in the retina. Our results indicate that a very signiﬁcant degree
of RGC purity was achieved.
RGCs isolated from saline injected retinas were used as controls.
The RGCswere lysed and subjected to immunoprecipitations using spe-
ciﬁc TrkB and Shp2 antibodies. Our studies indicate that TrkB and Shp2
reciprocally co-immunoprecipitate each other (Fig. 1B) and this associ-
ation is signiﬁcantly enhanced under both ON axotomy and increased
IOP stress conditions (Fig. 1C, D). There was no non-speciﬁc binding
to the non-immune IgGs. A much stronger interaction (2–3 folds) was
observed in RGCs isolated from chronically increased intra-ocular pres-
sure exposed retinas. Since glutamate excitotoxicity and oxidative
stress are major factors implicated in RGC degeneration in glaucoma
[34], we sought to determine the effect of these stress conditions on
TrkB–Shp2 interactions. The primary culture of rat RGCs as well as
the RGC-5 cell line were subjected to mild excitotoxic and oxidative
stress conditions by incubating the cells with Glu and H2O2 (Glu,
25 μM, H2O2, 2 μM) for 24 h followed by lysing the cells and subjecting
them toWestern blotting. A 2–3 fold increase in the reciprocal interac-
tion between these two proteins was observed in the rat RGCs while a
4–5 fold increase was observed in the RGC-5 cells (Fig. 2A, B).Fig. 2. TrkB–Shp2 interaction is enhanced in RGCs under excitotoxic and oxidative
stress conditions. The RGC-5 cell line as well as the primary rat RGCs maintained in
culture were subjected to Glu+H2O2 treatment for 24 h. A. Shp2 and B. TrkB immuno-
precipitations revealed their reciprocal interactions with each other. The binding was
signiﬁcantly enhanced upon exposure to stress conditions. Densitometric analysis of
TrkB binding to Shp2 and vice versa. Data are mean±SD, n=3 each, *pb0.001.3.2. Shp-2 regulates the TrkB activity in stressed RGCs
The RGCs isolated from control, ON axotomised and increased IOP
exposed retinas were lysed and equal amounts of proteins (10 μg) were
subjected to Western blotting, to analyse the expression of TrkB, BDNF
and Shp2 in these cells (Fig. 3A). Quantiﬁcation of the densitometric anal-
ysis of the band intensities normalised to the actin indicated that TrkB
levels increased signiﬁcantly 1 week after ON axotomy. The increase in
TrkB expression in increased IOP exposed RGCs was not observed to be
signiﬁcant. A two fold increase in BDNF levels was observed upon ONaxotomy. A signiﬁcant increase in BDNF levels was also observed under
increased IOP. No signiﬁcant changes were observed in the Shp2 expres-
sion levels in either of these conditions. The TrkB immunoprecipitates
Fig. 3. The TrkB kinase and Shp2 phosphatase activities are altered in RGCs under stress. A. Protein expression of TrkB, BDNF and Shp2 in the rat retinal ganglion cells under control,
ON axotomy and increased IOP conditions. Actin was used as the loading control in each case. Densitometric analysis of the band intensities relative to the actin expression in each
case is plotted (*pb0.05). B. Immunoprecipitation of TrkB from rat RGCs followed by probing with pTrkB Y515 antibody reveals a loss of TrkB phosphorylation under stress condi-
tions. Densitometric analysis in the linear range of detection revealed a signiﬁcantly greater loss in TrkB phosphorylation in increased IOP conditions compared to the controls as
well as ON axotomised retinas (*pb0.03). Immunoprecipitations of C. TrkB and D. Shp2 from RGC lysates (50 μg) followed by respective enzyme assays demonstrate a decline in
TrkB activity and a corresponding increase in Shp2 activity in RGCs exposed to ON axotomy and chronic IOP stress (*pb0.001). Data are mean±SD, n=3 each experiment.
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exposed retinas indicate a sharp decline in the Tyr515 phosphorylation
of the TrkB receptor using pTrkB Y515 antibody (1:1000, Abcam). The
loss of phosphorylation was higher in the increased IOP compared to
the ON axotomised retinas. Quantiﬁcation indicated that the phosphor-
ylation was reduced to 65% of the original intensity in ON axotomised
and 25% of the original in increased IOP exposed RGCs respectively
(Fig. 3B). TrkB immunoprecipitateswere also used to assess the tyrosine
kinase activity of the TrkB receptor in control RGC lysates and those ex-
posed to the above two stress conditions. Corresponding to the TrkB
phosphorylation we observed a decline in TrkB tyrosine kinase activ-
ity in the RGC stress models in vivo. The TrkB activity was reduced by
20 and 50% respectively in the ON axotomy and increased IOP stressFig. 4. Shp2 inhibition results in restoration of TrkB activity under the stress conditions.
RGC-5 cells were incubated with Shp2 inhibitor PHPS1 (5 μM, Santa Cruz) for 24 h
with or without Glu+H2O2 followed by washing the cells with PBS. A. Loss of Erk phos-
phorylation (Phospho-Erk1/2, 1:1000, Cell Signalling) but not the Akt indicated the
effectiveness of the inhibitor. B. TrkB immunoprecipitates from cell lysates (100 μg)
were immunoblotted and probed with phospho-TrkB Y515 and TrkB antibodies and
(C) assayed for TrkB kinase activity indicating an increase in TrkB tyrosine kinase activity
upon Shp2 inhibitionunder the indicated stress conditions. The protein expression of TrkB
in total cellular lysate is shown in each case. (Data are mean±SD, n=4, pb0.002).conditions (Fig. 3C). Conversely, an increase in the activity of Shp2
phosphatase (1.4 and 2 fold respectively)was observed in the RGC stress
models (Fig. 3D). The Shp2 assays were performed on the immunopre-
cipitates using equal amounts of Shp2 antibody. Similarly, a decline in
the TrkB Y515 phosphorylation and tyrosine kinase activity was observed
in the RGC-5 cells exposed to Glu+H2O2 mediated excitotoxic and oxi-
dative stress conditions. The phosphorylation analysis and kinase assays
were carried out on the immunoprecipitates using equal amounts of
TrkB antibody. The inhibition of Shp-2 phosphatase using Shp-2 inhibitor
(Santa Cruz, CA) in culture resulted in a sustained maintenance of nor-
mal TrkB phosphorylation and kinase activity even under the indi-
cated stress conditions (Fig. 4B,C). No effect of Shp2 inhibition on
the TrkB phosphorylation/activity was however observed under the
normal culture conditions. The expression of TrkB in each case is
shown (Fig. 4B). The in vivo Shp2 inhibition in RGC-5 cellswas established
by the loss of Erk phosphorylation and maintenance of Akt phosphory-
lation [35]. There was also no effect on the Shp2 expression (Fig. 4A).
Erk 1/2 (1:1000, Cell Signalling), and Actin (1:1000, Sigma) were used
as the loading controls.3.3. Caveolin interacts with Shp2 and undergoes hyperphosphorylation
in RGCs under stress conditions
The Shp2 interactions with cav isoforms were investigated in RGCs
under normal and glaucomatous stress conditions. Shp2 immunopre-
cipitations using equal amounts of Shp2 antibody followed by prob-
ing the immunoblots with cav-1 (Cell Signalling), 2 (Epitomics) and
3 (Cell Signalling) (1:1000) speciﬁc antibodies revealed their isoform
speciﬁc interactions with Shp2. While cav-1 and cav-3 depict signiﬁ-
cantly several fold increased binding to Shp2 under RGC stress, a re-
duced Shp2–cav-2 interaction was observed under these conditions.
RGC lysates indicate the expression of all these proteins under both
normal and stress conditions (Fig. 5A). Further, the immunoprecipita-
tions of cav1 and cav3 isoforms using equal amounts of speciﬁc anti-
bodies followed by probing the immunoblots with pY100 antibody
revealed that both cav-1 and cav-3 undergo hyperphosphorylation
uponON axotomy and under chronic IOP increase compared to the con-
trols. Densitometric analysis revealed that cav-1 phosphorylation is en-
hanced 4 folds in RGCs under stresswhile cav-3 depictsmore variability
Fig. 5. Caveolin undergoes hyperphosphorylation and binds to Shp-2 in RGCs under glaucomatous stress. A. Shp2 immunoprecipitations indicate that cav1 and 3 but not cav2 depict
an enhanced binding with Shp2 in RGCs from retinas exposed to ON axotomy or chronically increased IOP. Densitometric analysis revealed a signiﬁcantly greater binding in the RGC
stressmodels compared to the controls as indicated. Cav immunoprecipitation under chronically increased IOP conditionswas set as 100% (pb0.001). B. Cav1 and 3 immunoprecipitations
followed by probing with pY100 antibodies demonstrate that both cav1 and cav3 undergo hyper-phosphorylation in ON axotomy and chronically increased IOP conditions. The band in-
tensities were analysed for quantiﬁcation in the linear range of detection (pb0.002). The comparable expression of proteins in total cellular lysate is shown in each case (10 μg protein).
Data are mean±SD, n=3 each experiment.
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the RGCs (Fig. 5B).
3.4. Shp2–TrkB interaction is mediated through caveolin
Expressionof cav-1, 2 and3 isoformswasknockeddown in the rat ret-
inas and primary culture of RGCs using AONs as shown (Figs. 6A, 7A). The
quantiﬁcation of the band intensities indicated an efﬁcient and signiﬁcant
knock down of all the cav isoforms in vivo as well as under the culture
conditions (Figs. 6A, 7A). The 26 base chimeric sequence was 100% com-
plementary to themRNA sequences of cav-1α and β isoforms, 70% com-
plementary to the cav-2 and 89% complementary to the cav-3. RGC
lysates were subjected to immunoprecipitation using speciﬁc TrkB and
Shp2 antibodies (Fig. 6B). Densitometric quantiﬁcation of the results indi-
cate that the basal level of TrkB–Shp2 interaction was completely lost in
the cav knock down RGCs. The expression of the two proteins was ob-
served under both the control and cav knock down conditions. In anotherFig. 6. TrkB–Shp2 interaction in retinal ganglion cells is dependent on the protein caveolin
knock down (KD) of expression of cav 1, 2 and 3 isoforms in RGCs in vivo. Scrambled olig
markers Brn3a and Thy-1 is shown. Actin was used as loading control. Densitometric analysi
injections. B. Reciprocal immunoprecipitations of Shp2 and TrkB reveal that their mutual int
of the proteins is shown total cellular lysates. Densitometric analysis of the band intensities i
upon cav knock down. Data are mean±SD, pb0.001.set of experiments where primary RGCs maintained under deﬁned cul-
ture conditions were exposed to mild excitotoxic and oxidative stress in-
dicated previously, we further observed a loss of the interaction of TrkB
and Shp2 under cav knock down conditions. An interesting observation
was a partial restoration of the Shp2–TrkB interaction upon exposure of
the cav knock down cells to mild excitotoxic and oxidative stress using
Glu+H2O2 further indicating an increased binding of the two proteins
in stress conditions (Fig. 7B). RGCs maintained under normal conditions
and ones exposed to stress conditions alone were used as controls.
4. Discussion
The prolonged dephosphorylation of TrkB hampers the axonal re-
generation and other neuroprotective effects of BDNF and NT4 [36].
Our experiments establish that TrkB and Shp2 bind each other under nor-
mal physiological conditions in RGCs in vivo. The major ﬁnding of this
study is that TrkB tyrosine kinase activity in the RGCs under stress. A. Intravitreal administration of cav antisense (A) oligonucleotides (AONs) results in
onucleotide (S) injections were used as controls (n=20). Expression of ganglion cell
s of the band intensities is shown for each of the isoform and compared with scrambled
eraction was lost in RGCs isolated from cav knock down retinas. The expression of each
ndicated that there was almost a complete loss of interaction between the two proteins
Fig. 7. Stress exposure to caveolin knock down RGCs results in restoration of TrkB–Shp2
interactions. A. RGCs isolated from rat retinaswere treatedwith cav AONs to ablate cav ex-
pression. Treatmentwith scrambled oligoswas used as control. Expression of RGCmarker
Thy-1 is shown. Actin was used as loading control. Densitometric analysis of the knock
down of various cav isoforms is plotted. Data are mean±SD, n=4 each, pb0.001. B. Pri-
mary cultures of rat RGCs were either exposed to mild excitotoxic and oxidative stress
in normal or cav knock down conditions. RGCs under normal and cav knock down condi-
tions were used as controls. Reciprocal immunoprecipitations reveal that while TrkB–
Shp2 interaction is enhanced under the indicated stress conditions, it is vanished upon
cav ablation and partly restored when cav ablated RGCs are exposed to stress.
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Shp2 interaction in a pathological process. Even though TrkB signalling
can be stimulated by the BDNF/NT4 trophic factors, it will be short-lived
in such cases as TrkB is simultaneously being dephosphorylated and
deactivated by the associated phosphatase Shp2. Shp2 plays a role in
establishing the neuronal fate in retinal development and MAP kinase
signalling in Muller cells indicating it to be an important molecule in
the retina [37].
TrkB phosphorylation at Tyr515 is important for the binding of Shc
adaptor protein and downstream signalling events [38]. A loss of TrkB
phosphorylation was observed under the stress conditions. Parallel to
the loss of phosphorylation of the TrkB receptor at Y515, the TrkB tyrosine
kinase activity was down-regulated in both of the RGC stress models in
retina (Fig. 3B). The Shp2-TrkB association was observed both in vivo
(Fig. 1) and in the RGC neuronal culture under glaucomatous stress con-
ditions (Fig. 2). The associationwasmuchmore prominent in the case of
chronic stress associated with the increase of IOP compared to the acute
RGCdistressmodel of ON axotomy (Fig. 1). TrkB expressionwas found to
be enhanced in RGCs 1 week after ON axotomy corresponding to the
previous report indicating an initial upregulation of TrkB mRNA [39].
No signiﬁcant alteration in TrkB expression under the increased IOP
was observed (Fig. 3A). We also observed an increased BDNF expression
under both the acute as well as chronic stress models of RGCs at the
indicated time points, similar to previous reports [40]. However, the
TrkB phosphorylation was still observed to be decreased in both of
the models, indicating the involvement of other regulatory mecha-
nisms. A concurrent upregulation of Shp2 activity was observed upon
stress induction (Fig. 3D). The expression of Shp2 protein was however
unchanged under both stress conditions. Similar results were obtained
in the RGC-5 cells where stress induction signiﬁcantly decreased the
TrkB activity, while inhibiting Shp2 under stress conditions restored
the TrkB activity close to its original levels in the normal cells (Fig. 4).
These experiments indicate that retinal stress triggers an activation of
the Shp2 phosphatasewhich bindswith the TrkB receptor and eventually
lead to its deactivation. Inhibition of shp-2 activity in the normal cellshowever, did not signiﬁcantly enhance the TrkB activity indicating that
the Shp-2 undertakes a regulatory role for TrkB predominantly under
the stress conditions (Fig. 4). The Shp2deletion in cerebral neuronal cul-
tures alleviates TrkB inhibition and stimulates cell survival after treat-
ment with glutamate [12]. Genetic ablation of Shp2 abolished Erk
phosphorylation in the neural retina with pErk staining predominantly
co-localising in the Muller cell bodies in the ganglion cell layer (GCL)
and inner nuclear layer (INL) of retina leading to widespread retinal
degeneration [37]. We observed similar loss of Erk phosphorylation in
the RGC-5 cells upon pharmacological inhibition of Shp2 (Fig. 4). Shp2
also plays a role in the activation of Erk signalling in the cortical neurons
and several of the human neuroblastoma cell-lines [11,41]. Further, Shp2
binding to the TrkB receptors is dependent on the protein caveolin.
Cav-1−/− mice depict an enhanced Erk phosphorylation in the hippo-
campus [42]. Consistent with our in vivo ﬁndings in the RGCs, previous
studies indicate that cav-1 undergoes hyperphosphorylation under the
oxidative and osmotic cellular stress in ﬁbroblast cultures [43,44]. In
the trabecular meshwork cell lines obtained from glaucoma patients, a
decline in cav-1 phosphorylation and expression upon treatment dexa-
methasone was observed [45], indicating that cav phosphorylation in
glaucoma may be speciﬁc to RGCs. The effects of phosphorylation of
cav isoforms on the Erk signalling in RGCs are not known. Cav plays a
role in the Shp2 activation in astrocytes exposed to the oxidative stress
[46]. It is shown to play a role in themaintenance of blood retinal barrier
permeability, retinal homeostasis and outer retinal function [47,48]. The
cav gene locus also appears to play an important role in glaucoma path-
ogenesis [49,50]. We observed a hyper-phosphorylation of cav1 and 3 in
RGCs exposed to glaucomatous stress and a corresponding Shp2–cav in-
teraction and Shp2 activation leading to the TrkB dephosphorylation.We
observed an association of Shp2 with all the cav isoforms in the RGCs,
although the association was more prominent for cav-1 and cav-3
under the stress conditions (Fig. 5A). The cav2–Shp2 interactions were
surprisingly lost under the RGC stress conditions indicating that cav2 be-
haves differently compared to other isoforms. Corresponding to this inter-
action, we observed an enhanced tyrosine phosphorylation of the cav-1
and cav-3 (Fig. 5B). This experiment indicates that cav activates Shp2
which in turn dephosphorylates the TrkB receptor. Cav may bind to the
SH2 domains of Shp2 thereby relieving the auto-inhibition of the Shp2
and revealing its previously latent phosphatase activity [51]. It is possible
that cav acts as a signalling platform and recruits a pool of Shp2 in close
proximity to the TrkB receptor, which translates into the increased
dephosphorylation of the TrkB and downregulation of its signalling.
The essential role of this interaction was further conﬁrmed by the tran-
sient ablation of cav in RGCs in vivo (Fig. 6A) aswell as in the isolated rat
RGCs (Fig. 7A). Knock down of all cav isoforms to avoidmutual comple-
mentation, resulted in complete loss of the Shp2 and TrkB association
(Fig. 6B). Since cav2 is unstable in the absence of cav1 [52], cav1 knock
down further adds to the cav2 ablation. The association was partly re-
stored when the cav ablated cells were exposed to stress further indi-
cating that Shp2-TrkB association is enhanced under these conditions
(Fig. 7B). The results corresponded to those observed by inhibiting Shp2
under the stress conditions (Fig. 4B,C).
This mechanism indicates that TrkB activity is tightly regulated by
Shp2 in caveolin dependent manner in stressed RGCs, and could form
the molecular basis of why TrkB eventually fails to respond to the pro-
tective effects of BDNF in glaucoma. It will be interesting to determine
how this TrkB dephosphorylation is inﬂuenced by the Shp2 in other
neurodegenerative disorders. This study therefore, suggests Shp2 as a
promising drug target to protect TrkB activation and concomitantly pro-
vide neuroprotection to dying RGCs in glaucoma.
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